Physician profile
John Boyle
NPI 1104357706
$2,575.76
in general payments reported to CMS, 2019-2025
10 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.62 · 2022: $925 · 2023: $798 · 2024: $447 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,303 · Travel and Lodging: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.09 |
| Travel and Lodging | $285.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $774.30 | 2022 | |
| Genzyme Corporation | $500.84 | 2023-2025 | |
| Inspire Medical Systems, INC. | $445.65 | 2023 | Inspire |
| Glaxosmithkline, LLC. | $291.91 | 2023-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $161.71 | 2023-2024 | Dupixent |
| Aerin Medical INC. | $160.30 | 2023-2025 | |
| Intersect Ent, INC. | $136.20 | 2022 | |
| Medtronic, INC. | $62.62 | 2021 | |
| Stryker Corporation | $28.13 | 2025 | Audion Et Dilation System |
| Regeneron Pharmaceuticals, INC. | $14.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Boyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.